p38 MAPK in MDS

por Gañán‐Gómez, Irene, Bohannan, Zachary S, Garcia‐Manero, Guillermo
Publicado 2015

Isolation, culture, and immunophenotypic analysis of bone marrow HSPCs from patients with myelodysplastic syndromes

por Ganan-Gomez, Irene, Clise-Dwyer, Karen, Colla, Simona
Publicado 2022

Overexpression of miR-125a in Myelodysplastic Syndrome CD34(+) Cells Modulates NF-κB Activation and Enhances Erythroid Differentiation Arrest

por Gañán-Gómez, Irene, Wei, Yue, Yang, Hui, Pierce, Sherry, Bueso-Ramos, Carlos, Calin, George, Boyano-Adánez, María del Carmen, García-Manero, Guillermo
Publicado 2014

S185: TARGETING DNA2 OVERCOMES METABOLIC REPROGRAMMING IN 1Q21 MULTIPLE MYELOMA

por Thongon, Natthakan, MA, Feiyang, Lockyer, Pamela, Baran, Natalia, Liu, Jintan, Class, Caleb, Tan, Lin, Storti, Paola, Marchica, Valentina, Ganan-Gomez, Irene, Wildeman, Bethany, Adema, Vera, Lorenzi, Philip, Fonseca, Rodrigo, Chesi, Marta, Manasanch, Elisabeth, Viale, Andrea, Colla, Simona
Publicado 2023

Transcriptomic analysis implicates necroptosis in disease progression and prognosis in myelodysplastic syndromes

por Montalban-Bravo, Guillermo, Class, Caleb A., Ganan-Gomez, Irene, Kanagal-Shamanna, Rashmi, Sasaki, Koji, Richard-Carpentier, Guillaume, Naqvi, Kiran, Wei, Yue, Yang, Hui, Soltysiak, Kelly A., Chien, Kelly, Bueso-Ramos, Carlos, Do, Kim-Anh, Kantarjian, Hagop, Garcia-Manero, Guillermo
Publicado 2019

P723: CLINICAL AND MOLECULAR ASSOCIATIONS WITH OUTCOMES IN HIGHER RISK MYELODYSPLASTIC SYNDROMES TREATED WITH HYPOMETHYLATING AGENTS PLUS VENETOCLAX

por Bazinet, Alexandre, Prasad Desikan, Sai, LI, Ziyi, Venugopal, Sangeetha, Urrutia, Samuel, Montalban-Bravo, Guillermo, Sasaki, Koji, Chien, Kelly, Hammond, Danielle, Kanagal-Shamanna, Rashmi, Mirabella, Bailey, Hendrickson, Stephany, Romero, Liz, Colla, Simona, Ganan-Gomez, Irene, Jose Rodriguez-Sevilla, Juan, Kadia, Tapan, Dinardo, Courtney, Daver, Naval, Jabbour, Elias, Ravandi, Farhad, Kantarjian, Hagop, Garcia-Manero, Guillermo
Publicado 2023

Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neopl...

por Montalban-Bravo, Guillermo, Takahashi, Koichi, Patel, Keyur, Wang, Feng, Xingzhi, Song, Nogueras, Graciela M., Huang, Xuelin, Pierola, Ana Alfonso, Jabbour, Elias, Colla, Simona, Gañan-Gomez, Irene, Borthakur, Gautham, Daver, Naval, Estrov, Zeev, Kadia, Tapan, Pemmaraju, Naveen, Ravandi, Farhad, Bueso-Ramos, Carlos, Chamseddine, Ali, Konopleva, Marina, Zhang, Jianhua, Kantarjian, Hagop, Futreal, Andrew, Garcia-Manero, Guillermo
Publicado 2018

P1330: CYTOREDUCTIVE CHEMOTHERAPY COULD ACCELERATE THE LOSS OF CLONAL DIVERSITY IN HEMATOPOIETIC STEM CELLS AND PROMOTES THE CONVERGENT EVOLUTION OF THERAPY-RELATED CLONAL HEMATOPO...

por Uryu, Hidetaka, Saeki, Koichi, Nangalia, Jyoti, Chapman, Michael, Zhao, LI, Hsu, Joanne, Bueso-Ramos, Carlos, Chen, Shujuan, Yang, Hui, Dinardo, Courtney, Daver, Naval, Colla, Simona, Ganan-Gomez, Irene, Zhang, Jianhua, Song, Xingzhi, Thompson, Erika, Tang, Hongli, Orlowski, Robert Z, Champlin, Richard E., Qazilbash, Muzaffar H., Shpall, Elizabeth J., Futreal, Andrew, Garcia-Manero, Guillermo, Haeno, Hiroshi, Takahashi, Koichi
Publicado 2023

Hematopoiesis under telomere attrition at the single-cell resolution

por Thongon, Natthakan, Ma, Feiyang, Santoni, Andrea, Marchesini, Matteo, Fiorini, Elena, Rose, Ashley, Adema, Vera, Ganan-Gomez, Irene, Groarke, Emma M., Gutierrez-Rodrigues, Fernanda, Chen, Shuaitong, Lockyer, Pamela, Schneider, Sarah, Bueso-Ramos, Carlos, Montalban-Bravo, Guillermo, Class, Caleb A., Soltysiak, Kelly A., Pellegrini, Matteo, Sahin, Ergun, Bertuch, Alison A., DiNardo, Courtney D., Garcia-Manero, Guillermo, Young, Neal S., Dwyer, Karen, Colla, Simona
Publicado 2021

Targeting the EIF2AK1 Signaling Pathway Rescues Red Blood Cell Production in SF3B1-Mutant Myelodysplastic Syndromes With Ringed Sideroblasts

por Adema, Vera, Ma, Feiyang, Kanagal-Shamanna, Rashmi, Thongon, Natthakan, Montalban-Bravo, Guillermo, Yang, Hui, Peslak, Scott A., Wang, Feng, Acha, Pamela, Sole, Francesc, Lockyer, Pamela, Cassari, Margherita, Maciejewski, Jaroslaw P., Visconte, Valeria, Gañán-Gómez, Irene, Song, Yuanbin, Bueso-Ramos, Carlos, Pellegrini, Matteo, Tan, Tuyet M., Bejar, Rafael, Carew, Jennifer S., Halene, Stephanie, Santini, Valeria, Al-Atrash, Gheath, Clise-Dwyer, Karen, Garcia-Manero, Guillermo, Blobel, Gerd A., Colla, Simona
Publicado 2022

Evolutionary action score identifies a subset of TP53 mutated myelodysplastic syndrome with favorable prognosis

por Kanagal-Shamanna, Rashmi, Montalban-Bravo, Guillermo, Katsonis, Panagiotis, Sasaki, Koji, Class, Caleb A., Jabbour, Elias, Sallman, David, Hunter, Anthony Michael, Benton, Christopher, Chien, Kelly S., Luthra, Rajyalakshmi, Bueso-Ramos, Carlos E., Kadia, Tapan, Andreeff, Michael, Komrokji, Rami S., Al Ali, Najla H, Short, Nicholas, Daver, Naval, Routbort, Mark J., Khoury, Joseph D., Patel, Keyur, Ganan-Gomez, Irene, Wei, Yue, Borthakur, Gautam, Ravandi, Farhad, Do, Kim-Anh, Soltysiak, Kelly A., Lichtarge, Olivier, Medeiros, L. Jeffrey, Kantarjian, Hagop, Garcia-Manero, Guillermo
Publicado 2021

Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy

por Ganan-Gomez, Irene, Yang, Hui, Ma, Feiyang, Montalban-Bravo, Guillermo, Thongon, Natthakan, Marchica, Valentina, Richard-Carpentier, Guillaume, Chien, Kelly, Manyam, Ganiraju, Wang, Feng, Alfonso, Ana, Chen, Shuaitong, Class, Caleb, Kanagal-Shamanna, Rashmi, Ingram, Justin P., Ogoti, Yamini, Rose, Ashley, Loghavi, Sanam, Lockyer, Pamela, Cambo, Benedetta, Muftuoglu, Muharrem, Schneider, Sarah, Adema, Vera, McLellan, Michael, Garza, John, Marchesini, Matteo, Giuliani, Nicola, Pellegrini, Matteo, Wang, Jing, Walker, Jason, Li, Ziyi, Takahashi, Koichi, Leverson, Joel D., Bueso-Ramos, Carlos, Andreeff, Michael, Clise-Dwyer, Karen, Garcia-Manero, Guillermo, Colla, Simona
Publicado 2022

Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy

por Ganan-Gomez, Irene, Yang, Hui, Ma, Feiyang, Montalban-Bravo, Guillermo, Thongon, Natthakan, Marchica, Valentina, Richard-Carpentier, Guillaume, Chien, Kelly, Manyam, Ganiraju, Wang, Feng, Alfonso, Ana, Chen, Shuaitong, Class, Caleb, Kanagal-Shamanna, Rashmi, Ingram, Justin P., Ogoti, Yamini, Rose, Ashley, Loghavi, Sanam, Lockyer, Pamela, Cambo, Benedetta, Muftuoglu, Muharrem, Schneider, Sarah, Adema, Vera, McLellan, Michael, Garza, John, Marchesini, Matteo, Giuliani, Nicola, Pellegrini, Matteo, Wang, Jing, Walker, Jason, Li, Ziyi, Takahashi, Koichi, Leverson, Joel D., Bueso-Ramos, Carlos, Andreeff, Michael, Clise-Dwyer, Karen, Garcia-Manero, Guillermo, Colla, Simona
Publicado 2022